Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-898 Oct 29 Written By Hannah Schaeffer Full Press Release → Hannah Schaeffer
Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-898 Oct 29 Written By Hannah Schaeffer Full Press Release → Hannah Schaeffer